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Abstract 
BACKGROUND: Purine intake is a known risk factor for incident gout; however, no study has 
examined whether its intake triggers recurrent gout attacks over a short period of time. 
 
METHODS: We conducted a case-crossover study to assess purine intake from various sources 
and the risk of recurrent gout attacks.  Patients with a history of gout were recruited online and 
were followed for one year.  Frequency of food intake with serving size specified on each day 
over the 2-day period prior to an acute gout attack and over the 2-day period during an 
intercritical period was assessed using an online questionnaire.  Total amount of purine intake 
over these 2-day periods was estimated and divided into quintiles.  We performed conditional 
logistic regressions to examine the relation of total purine intake as well as purine from animal 
(i.e., meat, seafood) and non-animal (i.e., fruits, vegetables) sources to the risk of recurrent gout 
attacks while adjusting for use of alcohol, allopurinol, and diuretics. 
 
RESULTS: We analyzed data from 633 participants with gout.  Compared with the lowest 
quintile of total purine intake over a 2-day period, odds ratios (OR) of recurrent gout attacks 
were 1.18, 1.39, 2.22, and 4.76, respectively, with each increasing quintile (p for trend < 0.001).  
The corresponding ORs were 1.45, 1.43, 2.00, and 2.97 for increasing quintiles of purine intake 
from animal sources (p for trend <0.001), and 1.11, 1.04, 1.38, and 1.69 for those of purine 
intake from non-animal sources (p<0.003), respectively.  The effect of purine intake persisted 
across subgroups by sex, use of alcohol, diuretics, and allopurinol (all p-values for trend <0.001).  
   
CONCLUSION: These large-scale study findings indicate that acute purine intake increases the 
risk of recurrent gout flares up to five times.  Avoiding or reducing purine purine-rich foods, 
especially those with ananimal origin (e.g…………), would help reduce the risk of recurrent 
gout attacks.       
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Gout is a common and excruciatingly painful inflammatory arthritis caused by 
hyperuricemia.  While the pathophysiology of gout is well understood and efficacious 
pharamacological regimens are available, the disease burden of gout remains substantial and is 
growing (1).  In addition, many patients with gout continue to experience recurrent gout attacks 
(2, 3).  Such attacks are frequently ascribed to triggering events such as dietary intake, and 
avoidance of these triggers is widely promulgated as a central strategy in the management of 
gout.   Despite this advice on dietary strategies being widespread the risk purine intake confers 
on gout recurrence is unknown. 
 
Purine intake is associated with hyperuricemia (4) and an increased risk of incident gout (5).  
To date, however, no study has examined whether purine-rich foods intake triggers recurrent 
gout attacks over a short period of time.  Clarifying this link and quantifying its magnitude 
would help gout patients make informed decisions on food items that should be avoided to help 
lower their risk of recurrent gout attacks.   
 
To address these issues, we conducted an online case-crossover study and examined the 
relation of total amount of purine intake as well as purine from animal and non-animal sources to 
the risk of recurrent gout attacks.  We also assessed whether the impact of purine intake varied 
by other known major risk factors of gout. 
 
Methods 
The details of the Online Case-crossover Study of Triggers for Recurrent Gout Attacks have 
been described previously (6).  Briefly, we constructed a study website on an independent secure 
server in the Boston University School of Medicine domain (https//dcc2.bumc.bu.edu/GOUT).  
The study was advertised on the Google search engine (www.Google.com) by linking an 
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advertisement to the search term ‘gout.’  Interested individuals who clicked on the study 
advertisement were directed to the study website.  To be eligible for the study, a subject had to 
report gout diagnosed by a physician, have had a gout attack within the past 12 months, be at 
least 18 years of age, reside in the U.S., and agree to release medical records pertaining to gout 
diagnosis and treatment.  To confirm a subject’s diagnosis of gout, we obtained medical records 
pertaining to the participant’s gout history and/or a checklist of gout symptoms completed by the 
subject’s physician.  Two rheumatologists (DJH, TN) reviewed all medical records and the 
checklists and determined whether the participants had a diagnosis of gout according to the 
American College of Rheumatology Criteria for gout (7).   
 
Participants were asked to complete a gout Hazard-period Questionnaire when experiencing 
a recurrent gout attack.  Data were collected regarding the onset date of the recurrent gout attack, 
clinical symptoms and signs, medications used to treat the attack, and presence of a set of 
purported risk factors during the 2-day period prior to the gout attack.  Participants also 
completed a Control-period Questionnaire at four time points: at study entry (for the subjects 
who entered the study because of experiencing gout flare), and at 3, 6, 9, and 12 (for the subjects 
who entered the study at intercritical period) months of follow-up.  The questions used to assess 
the risk factors during the control period were the same as those used in the hazard period. 
 
Questions on food intake included the number of servings and serving size of each food 
consumed on each day of the past 2 days over the control and the hazard periods.  We estimated 
the total amount of purine intake from all foods consumed during these periods according to the 
purine content table of different food items (8, 9).       
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Statistical Analysis 
The total amount of purine intake over two days was divided into quintile groups.  We 
examined the relation of total purine intake to the risk of recurrent gout attacks using a 
conditional logistic regression model.  In a multivariable regression model we adjusted for use of 
alcohol, allopurinol, and diuretics.  To graphically display the relation between the amount of 
purine intake and the risk of recurrent gout attacks, we used restricted quadratic splines 
conditional logistic model to smooth the dose-response curve (10).  Using the same approach, we 
evaluated the effect of purine intake from animal sources (i.e., meat, seafoods) separately from 
non-animal sources (i.e., fruits, vegetables) on the risk of recurrent gout attacks.  Finally, we 
assessed potential subgroup effects of purine consumption according to gender, alcohol use 
(abstainer vs. drinker), allopurinol use (yes vs. no) and diuretic use (yes vs. no) and tested for a 
modification of effect by adding an interaction term to our final multivariable regression models.   
 
Results 
We analyzed 633 gout patients who completed both Hazard-Period and Control-Period 
Questionnaires.  Among *** subjects (**.*%) who returned a signed Medical Record Release 
Form, we obtained *** subjects’ medical records or physician’s checklists from their physicians,  
***(**.*%) met American College of Rheumatology Criteria for gout.   
 
The characteristics of the participants are presented in Table 1.  The average age of the 
participants was ** years.  Participants were predominantly male (**%), White (**%), and over 
a half received a college education.  Subjects were recruited from ** states and the District of 
Columbia.  During the one-year follow-up period, we documented 1,247 recurrent gout attacks.  
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The median time between the gout attack onset and completion of the Hazard-Period 
Questionnaire was ** days.    
 
As shown in Table 2, compared with the lowest quintile of purine intake over a 2-day period 
(approximately 21 oz of beef, or 17 cups of broccoli), the odds ratios (11) for recurrent gout 
attacks were 1.18, 1.39, 2.22 and 4.76 (approximately 85 oz of beef or 68 cups of broccoli for the 
highest quintile categories), respectively, with each increasing quintile (p for trend < 0.001).  The 
exposure-effect curve, shown in Figure 1, indicated an apparent dose-response relationship 
between total purine intake and risk of recurrent gout attacks.  
  
The impact of purine intake from animal sources on the risk of recurrent gout attacks was 
greater than that from non-animal sources (Figure 2).  Compared with the lowest quintile of 
purine intake from animal sources, ORs of recurrent gout attacks were 1.46, 1.43, 2.00, and 2.97, 
respectively with each increasing quintile (P for trend < 0.001).  The corresponding ORs for 
purine intake from non-animal sources were 1.12, 1.04, 1.39, and 1.67 (P for trend < 0.001), 
respectively.  When we explored the relations according to cross-classification by tertiles of the 
two purine sources (Table 3), the relative effect on risk of recurrent gout attacks was greater for 
purine categories of animal sources than those of non-animal sources. 
 
The effect of purine intake on the risk of recurrent gout attacks persisted across subgroups 
by sex, use of alcohol, diuretics, and allopurinol (all p-values for trend <0.001) (Table 4) and did 
not vary significantly by these factors (all p-values for interaction > 0.5).     
 
Discussion 
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Although purine-rich food intake have been considered a risk factor for recurrent gout 
attacks, to our knowledge, this is the first large-scale study to formally test this hypothesis and 
quantify the magnitude of the association.  We found that purine intake of more than 2300 mg 
(give some common food examples that may contain this much purine) over a 2-day period 
(highest quintile of purine intake) increases the risk of recurrent gout flares up to five times 
compared with purine intake of less than 1150 mg over a 2-day period.  These associations were 
independent of other risk factors for gout such as sex, alcohol intake, and use of allopurinol or 
diuretics.  The associations persisted across subgroups stratified by these major risk factors.  We 
also found that the impact from animal purine sources was substantially greater than that from 
non-animal purine sources.   
 
Recurrent flares are the hallmark of intercurrent gout.  In our online gout study we have 
found that approximately two thirds of participants in our online gout study who had gout attacks 
in the previous year experienced at least one recurrent gout attack over one year (3).  Similarly, 
earlier reports estimated that 60% of patients with newly diagnosed gout had a second attack 
within the first year, 78% had a second attack within two years, and only 7% escaped recurrence 
of gout over a 10-year period (2).  While urate lowering therapy (ULT) (12) (e.g., allopurinol in 
>90% of cases in the US and Europe) can be generally effective in lowering levels of SUA and 
the risk of gout when used compliantly, the current practice standards limit ULT to specific 
indications such as frequent gout attacks, tophaceous gout, and advanced gout, primarily due to 
rare but serious side effects (11).  Thus, when these indications are not yet met, dietary 
manipulation and other risk factor modifications are the only acceptable options.  Similarly, 
these non-pharmacologic measures play an exclusive role in asymptomatic hyperuricemia and 
when the ULTs are successfully terminated after durable remission of gout.  Furthermore, these 
    Yuqing, Purine/gout manuscript 
 
recommendations continue an adjunct measures to aid pharmacologic ULT regardless of the 
stage of gout, even when ULTs are indicated. 
 
Intake of purine-rich foods has long been postulated to increase the risk of recurrent gout 
attacks.  These observations are supported by metabolic experiments in animals and humans that 
examined the impact of artificial short-term loading of purified purine on the serum uric acid 
level (not gouty arthritis per se) (13-16).  More recently, studies have shown that higher levels of 
meat/seafood consumption are associated with higher levels of serum uric acid (4), and 
habitually higher meat and seafood intake is strongly associated with an increased risk of 
incident gout (5) among individuals without gout at baseline.  Our findings extend the evidence 
to a clinically relevant context, recurrent gout flares among patients with existing gout, and 
indicate that avoiding or reducing purine-rich foods, especially from animal origin, would help 
reduce recurrent gout attacks in these contexts.  
 
Several features of the current study are worth noting.  Identifying potential triggers for 
recurrent gout attacks and assessing their effects are challenging when using conventional study 
designs.  For example, a case-control study would pose difficulties for control selection, while a 
cohort design would be costly and unwieldy for participants.  The case-crossover study uses each 
case as his/her own control and is highly adaptable to examining associations of triggers with 
acute events.  Furthermore, to help overcome recruitment challenges of conventional study 
designs, we used the Internet to recruit subjects with intercritical gout from the entire US.  These 
methods allowed us to assess both exposure and disease occurrence in real-time while 
minimizing the potential recall bias.  
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Our study has some limitations.  While the current study design allowed us to assess the 
effects of changing levels of purine intake on the risk of recurrent gout attacks, it is not ideal for 
examining the effects of a habitual level of purine consumption.  Because dietary consumption 
was self-reported by questionnaire, some misclassification of exposure is inevitable.  In the 
current study we estimated the amount of purine from various foods consumed over the 2-day 
period according to the serving size and number of servings of each food consumed, as well as 
the purine content of each food according to a previously published database.  While this method 
is unable to provide precise estimates of absolute purine intake, it allows us to classify the purine 
intake over a specific time period relative to that over other time periods within the same person.  
Any misclassification in ranking purine intake, if it occurred, would likely be random; thus, the 
real effect of purine on the risk of recurrent gout attacks is probably greater than what we have 
observed.  We did not collect data on serum uric acid levels for each study participant; thus, we 
were unable to assess whether purine-rich food intake over a short period would increase the risk 
of recurrent gout attacks even among subjects whose serum uric acid is below the threshold 
level.  Nevertheless, when we limited our analysis to subjects who reported taking allopurinol at 
the baseline visit and all subsequent followup visits (n = 208), the risk of recurrent gout attacks 
still increased when individuals increased their purine intake.    
 
In conclusion, these large-scale study findings indicate that acute purine intake increases the 
risk of recurrent gout flares up to five times.  We also found that the impact from animal purine 
sources was substantially greater than that from non-animal purine sources.  Avoiding or 
reducing purine-rich foods, especially from animal origin (e.g.), would help reduce the risk of 
recurrent gout attacks.  
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Table 1.  Characteristics of Participants in the Internet-based Case-Crossover Study of Gout 
 
Characteristics  
  
Sex (n, %)  
    Men 494(78.0) 
    Women   39 (19.8) 
  
Age (median, range)  54(**-**) 
  
Education (n, %)  
    High School Graduate   
    Some College/Technical School  
    College Graduate  
    Completed Professional or Graduate School  
  
Household Income (n, %)  
    <25,000  
    25,000-49,999  
    50,000-74,999  
    75,000-99,999  
     >100,000  
    Missing  
  
Race (n, %)  
    Black  
    White 558(88.2) 
    Other  
    Missing  
  
Number of days between attack date and logon (median, 
range) 
 3 (0-24) 
  
Years of Disease Duration (Median, range)   5.0 
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Table 2.   Total Purine Consumption and Risk of Recurrent Gout Attack   
 
Quintiles of total 
purine intake 
over past-2days  
Number of  
control periods  
Number of  
hazard periods 
Crude OR  
(95% CI) 
Adjusted OR  
(95% CI)** 
1 (853 mg)* 363 203 1.0 1.0 
 
2 (1303 mg)   359 209 1.21 (0.92-1.59) 1.18 (0.89-1.56) 
 
3 (1739 mg) 348 219 1.43 (1.06-1.91) 1.39 (1.03-1.88) 
 
4 (2281 mg) 301 267 2.32 (1.72-3.13) 2.22 (1.63-3.02) 
 
5 (3479 mg) 218 349 4.98 (3.55-6.98) 4.76 (3.37-6.72) 
P for trend    < 0.001 
 
*Median value of purine intake over 2-day period 
   
** Adjusted for use of alcohol, allopurinol, and diuretics  
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Table 3.  Odds Ratios of Recurrent Gout Attacks According to Tertile Categories of Purine from 
Animal and Non-animal Sources 
 
 
Tertiles of Purine from 
Non-animal sources 
Tertiles of Purine Intake from Animal Sources 
1*                                2                                3 
 
1 
       Control Hazard  Control Hazard Control  Hazard 
No. Visits 261 155 183 126 116 104 
OR** (95% CI)      1.0   1.39 (0.98, 1.97) 
 
 1.99 (1.33, 2.97) 
 
 
2 
       
No. Visits 192 114 220 129 144 146 
OR (95% CI)     1.22 (0.86, 1.74)   1.42 (1.00, 2.03) 
 
 2.46 (1.69, 3.59) 
 
       
3 No. Visits 130 90 163 126 178 257 
OR (95% CI)     1.45 (0.96, 2.19)   1.83 (1.23, 2.71)  3.82 (2.63, 5.55) 
 
 
*1 represents the lowest tertile group and 3 represents the highest tertile group  
 
**Adjusted for alcohol intake, use of diuretic and allopurinol  
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 Table 4.   Total Purine Consumption over Past 2-day and Risk of Recurrent Gout Attack by Sex, 
Alcohol Consumption, Use of Diuretic and Allopurinol   
 
Other risk 
factors 
Quintile of 
purine intake* 
Number of 
control periods 
Number of 
hazard  periods 
Adjusted OR 
(95% CI)** 
P for 
trend 
 1 (lowest)  290 156 1.0  
 2 285 162 1.11 (0.81-1.53)  
Men 3 275 171 1.37 (0.97-1.93) <0.001 
 4 235 212 2.35 (1.65-3.34)  
 5 (highest) 175 271 4.82 (3.25-7.16)  
      
 1 (lowest)  73 47 1.0  
 2 74 47 1.46 (0.80-2.67)  
Women 3 73 48 1.45 (0.78-2.69) <0.001 
 4 66 55 2.86 (0.98-3.51)  
 5 (highest) 43 78 4.72 (2.28-9.78)  
      
 1 (lowest)  261 132 1.0  
 2 262 155 1.26 (0.90-1.76)  
Alcohol drinkers 3 247 141 1.36 (0.95-1.96) <0.001 
 4 217 182 2.27 (1.57-3.30)  
 5 (highest) 157 246 5.13 (3.40-7.75)  
      
 1 (lowest)  102 71 1.0  
 2 97 54 1.02 (0.61-1.69)  
Alcohol  3 101 78 1.46 (0.86-2.48) <0.001 
abstainers 4 84 85 2.23 (1.31-3.81)  
 5 (highest) 61 103 4.38 (2.36-8.15)  
      
 1 (lowest)  109 74 1.0  
 2 101 67 1.06 (0.81-1.53)  
Diuretic users 3 101 70 1.42 (0.97-1.93) <0.001 
 4 82 77 1.76 (1.03-3.00)  
 5 (highest) 66 122 4.13 (2.26-7.54)  
      
 1 (lowest)  254 129 1.0  
 2 258 142 1.28 (0.91-1.80)  
Diuretic  3 247 149 1.44 (1.00-2.08) <0.001 
Non-users 4 219 190 2.56 (1.76-3.72)  
 5 (highest) 152 227 5.30 (3.48-8.09)  
      
 1 (lowest)  119 49 1.0  
 2 114 59 1.41 (0.80-2.50)  
Allopurinol users 3 247 51 1.44 (0.75-2.77) <0.001 
 4 219 61 1.70 (0.88-3.29)  
 5 (highest) 152 85 5.51 (2.57-11.8)  
      
 1 (lowest)  224 154 1.0  
 2 245 150 1.05 (0.75-1.48)  
Allopurinol 3 229 168 1.30 (0.90-1.86) <0.001 
Non-users 4 204 206 2.19 (1.50-3.20)  
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 5 (highest) 153 264 4.42 (2.90-6.73)  
 
*1 represents the lowest quintile group and 5 represents the highest quintile group. 
           ** Adjusted for alcohol intake, use of diuretic and allopurinol
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Figure 1.  Estimated Odds Ratio and 95% Confidence Intervals for Recurrent Gout Attacks  
According to Amount of Purine Intake during the Past 2 Days  
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Figure 2.  Estimated Odds Ratio for Recurrent Gout Attacks Related to the Source of Purine 
Intake    
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